Log in to search using one of your social media accounts:

 

AbbVie must pay $15 million in Depakote birth-defect trial: jury
(Reuters) - A federal jury on Friday awarded $15 million to a 10-year-old boy whose mother blamed his birth defect on AbbVie Inc's bipolar disorder drug Depakote that she took while pregnant, in the latest trial among hundreds of lawsuits over the product. (Source: Reuters: Health)
Source: Reuters: Health - June 9, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Woman awarded $15 million from AbbVie after suing over Depakote drug
(Reuters) - A federal jury on Friday awarded $15 million to a California woman who blamed her son's birth defects on AbbVie Inc's bipolar disorder drug Depakote, in the latest trial to spill out of lawsuits over the product. (Source: Reuters: Health)
Source: Reuters: Health - June 9, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

AbbVie suffers $15 million loss in Depakote birth-defect trial
(Reuters) - A federal jury on Friday awarded $15 million to a California woman who blamed her son's birth defects on AbbVie Inc's bipolar disorder drug Depakote, in the latest trial to spill out of hundreds of lawsuits over the drug. (Source: Reuters: Health)
Source: Reuters: Health - June 9, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Depakote (Depakote Divalproex Sodium Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 17, 2017 Category: Drugs & Pharmacology Source Type: news

Antidepressants and pregnancy: More research needed
Follow me at @Drmoniquetello For many women, pregnancy and the arrival of a new baby is a joyous time — but not for every woman. Recently, postpartum depression — extreme feelings of sadness and anxiety following the birth of a child — has come out from the shadows. But what about depression during pregnancy? It’s more common than you think: as many as 14% to 23% of pregnant women will experience symptoms of depression. It’s of sufficient public health concern that the U.S. Preventive Services Task Force recommends screening all pregnant women and new moms for depression. However, treatin...
Source: New Harvard Health Information - May 19, 2016 Category: Consumer Health News Authors: Monique Tello, MD, MPH Tags: Anxiety and Depression Behavioral Health Drugs and Supplements Family Planning and Pregnancy Source Type: news

Critical epilepsy drug begins shipments after 10 month shortage
Apotex, Canada's largest manufacturer of Divalproex Sodium, is expected to restart shipments of the essential epilepsy drug after encountering problems with manufacturing 10 months ago. (Source: CBC | Health)
Source: CBC | Health - April 22, 2016 Category: Consumer Health News Tags: News/Health Source Type: news

FDA Drug Safety Communication: Valproate Anti-seizure Products Contraindicated for Migraine Prevention in Pregnant Women due to Decreased IQ Scores in Exposed Children
The U.S. Food and Drug Administration (FDA) is advising health care professionals and women that the anti-seizure medication valproate sodium and related products, valproic acid and divalproex sodium, are contraindicated and should not be taken by pregnant women for the prevention of migraine headaches. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 26, 2016 Category: Drugs & Pharmacology Source Type: news

Depakote (Depakote Divalproex Sodium Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 29, 2016 Category: Drugs & Pharmacology Source Type: news

Dr Reddy's Laboratories recalls anti-seizure, hypertension drugs from US market
The firm has started recalling Divalproex Sodium extended-release tablets as it has failed dissolution tests. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 29, 2015 Category: Pharmaceuticals Source Type: news

What is the Epidemiology of SMA Syndrome?
Discussion Superior mesenteric artery syndrome (SMAS) is caused by the compression of the superior mesenteric artery (SMA) against the 3rd part of the duodenum creating a proximal intestinal obstruction. It is relatively rare and can be hard to distinguish from other causes of intestinal obstruction. Normally the SMA arises from the anterior aorta around the L1 vertebra. It extends anteriorly and caudally into the mesentery of the small bowel. The angle between the SMA and aorta is called the aortomesenteric angle and is usually 38-65°. The distance between the SMA and aorta is usually 10-20 mm. Within the aortomesent...
Source: PediatricEducation.org - June 1, 2015 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Depakote Sprinkle Capsules (Divalproex Sodium Sprinkle Capsules) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 20, 2015 Category: Drugs & Pharmacology Source Type: news

Serotonin syndrome masked by concomitant ingestion of Zoloft with benzodiazepine in suicide attempt in a young healthy male -
This case report discusses the history and management of a schizophrenic patient, a 18-year-old man, who had taken a massive overdose of clonazepam, abilify, depakote, zoloft and seroquel altogether. After discontinuation of these drugs and administration ... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - November 15, 2014 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Everything You Need to Know About Depakote
Facts about Depakote - generic divalproex sodium or sodium valproate - which is a mood stabilizer for bipolar disorder (also for epilepsy and migraine). (Source: About.com Bipolar Disorder)
Source: About.com Bipolar Disorder - May 1, 2014 Category: Psychiatry Authors: bipolar.guide at about.com Tags: health Source Type: news

Flood Law Group Now Available to Investigate Claims on behalf of...
Flood Law Group announced today that they are available to investigate the claims of parents of children who suffer from birth defects that are possibly linked to the prescription drug Depakote. Flood...(PRWeb April 24, 2014)Read the full story at http://www.prweb.com/releases/depakote-birth-defects/flood-law-group/prweb11722720.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 25, 2014 Category: Pharmaceuticals Source Type: news

New Depakote Lawsuit Alleges Acute Liver and Kidney Failure: Now,...
On December 16, a new lawsuit was filed by an Orleans Parish woman in Louisiana Eastern District Court alleging that she suffered acute liver and kidney failure from Depakote. In light of this news,...(PRWeb January 21, 2014)Read the full story at http://www.prweb.com/releases/2014/01/prweb11503121.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 21, 2014 Category: Pharmaceuticals Source Type: news

Zoll, Kranz & Borgess Files Depakote Lawsuit Against Drug...
Zoll, Kranz & Borgess (ZKB) has filed suit against drug manufacturers, Abbott Laboratories and AbbVie, Inc. on behalf of a child with multiple autism spectrum disorders, whose mother was...(PRWeb January 11, 2014)Read the full story at http://www.prweb.com/releases/2014/01/prweb11481064.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 11, 2014 Category: Pharmaceuticals Source Type: news

Breakthrough made in identifying effect of epilepsy treatment
50 years after valproate was first discovered, research published in the journal Neurobiology of Disease, reports how the drug works to block seizure progression. Valproate (variously labelled worldwide as Epilim, Depacon, Depakene, Depakote, Orlept, Episenta, Orfiril, and Convulex) is one of the world's most highly prescribed treatments for epilepsy. It was first discovered to be an effective treatment for epilepsy, by accident, in 1963 by a group of French scientists... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 4, 2013 Category: Consumer Health News Tags: Epilepsy Source Type: news

New Depakote Marketing Lawsuit on Racketeering: Now, AttorneyOne Can...
As Businessweek published on August 16, a new lawsuit alleges that Abbott engaged in racketeering when it led an effort to market Depakote for unapproved uses. In light of this news, AttorneyOne, a...(PRWeb August 19, 2013)Read the full story at http://www.prweb.com/releases/2013/8/prweb11037247.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 20, 2013 Category: Pharmaceuticals Source Type: news

Attorney John J. Driscoll Comments on New FDA Warning about Depakote...
The lawyer and consumer rights advocate from the Driscoll Firm, P.C., points to a study cited by the FDA, indicating a connection between pregnant women using migraine headache medications such as...(PRWeb August 06, 2013)Read the full story at http://www.prweb.com/releases/depakote-birth-defects/fda-warning/prweb10995025.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 8, 2013 Category: Pharmaceuticals Source Type: news

Some Ideas for Handling Treatment-Resistant Bipolar Disorder
Bipolar disorder is being better understood each day. There is also ongoing research into its treatment. But successfully treating bipolar disorder can involve several medication trials, and it can take years to achieve remission. Even if remission is attained, recurrence is the rule — not the exception. It’s not uncommon for all first-line treatments to be exhausted. People in this situation may be considered by mental health professionals to be treatment-resistant. Luckily, there are treatments that can be tried when first-line, and even second-line, treatments for bipolar disorder fail. What is Treatment R...
Source: Psych Central - June 8, 2013 Category: Psychiatry Authors: Natasha Tracy Tags: Anticonvulsants Antidepressants Atypical Antipsychotics Bipolar Cognitive-Behavioral Disorders General Medications Mood Stabilizers Psychotherapy Treatment Abilify Aripiprazole Bipolar Disorder Clinicians Consensus Depakote Source Type: news

Some Ideas for Handling Treatment-Resistant Bipolar Disorder
Bipolar disorder is being better understood each day. There is also ongoing research into its treatment. But successfully treating bipolar disorder can involve several medication trials, and it can take years to achieve remission. Even if remission is attained, recurrence is the rule — not the exception. It’s not uncommon for all first-line treatments to be exhausted. People in this situation may be considered by mental health professionals to be treatment-resistant. Luckily, there are treatments that can be tried when first-line, and even second-line, treatments for bipolar disorder fail. What is Treatment R...
Source: Psych Central - June 8, 2013 Category: Psychiatry Authors: Natasha Tracy Tags: Anticonvulsants Antidepressants Atypical Antipsychotics Bipolar Cognitive-Behavioral Disorders General Medications Mood Stabilizers Psychotherapy Treatment Abilify Aripiprazole Bipolar Disorder Clinicians Consensus Depakote Source Type: news

FDA warns pregnant women to not use certain migraine prevention medicines
The U.S. Food and Drug Administration is alerting health care providers and patients that medications including and related to valproate sodium can cause decreased IQ scores in children whose mothers took the medication during pregnancy. Therefore, these drugs are being contraindicated for (should never be used by) pregnant women for the prevention of migraine headaches. Valproate products include valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER), valproic acid (Depakene and Stavzor), and their generics. (Source: Food and Drug Administration)
Source: Food and Drug Administration - May 6, 2013 Category: American Health Source Type: news

New Study Links Depakote (Valproate) to Birth Defects: Now,...
A new study published on March 6th, 2013 in the journal Acta Neurologica Scandinavica revealed that valproate (Depakote) is linked with birth defects. In light of this news, AttorneyOne, a recognized...(PRWeb April 12, 2013)Read the full story at http://www.prweb.com/releases/2013/4/prweb10623891.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 14, 2013 Category: Pharmaceuticals Source Type: news

New Lawsuit on Depakote Birth Defects: Now, AttorneyOne Can Provide...
According to court documents, on January 25th, 2013 a South Carolina man filed a lawsuit in Illinois Southern District Court alleging he suffered birth defects as a result of his mother’s ingestion of...(PRWeb February 18, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10439965.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 18, 2013 Category: Pharmaceuticals Source Type: news

New Study Links Valproate (Depakote) during Pregnancy to Lower IQ:...
On January 23rd 2013, the Lancet Neurology published the results of a new study revealing that children of mothers who take valproate (incl. Depakote) during pregnancy have lower IQ scores at age 6....(PRWeb January 25, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10358398.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 26, 2013 Category: Pharmaceuticals Source Type: news